Immuni T proudly announces the appointment of Dr. Farideh Nourian as the new member of board of directors. Dr. Nourian will serve as Director of Business Development and brings a wealth of experience and expertise that were gained from twenty years of working as assistant professor in academia and Principal Scientist at CRO, Biotech and Pharmaceutical companies in North America such as Kiadis Pharma, Charles River Laboratories (CRL) and Algorithme Pharma. Most recently, Dr. Nourian has been involved in a string of successful consulting for Pliant Pharmaceutics in USA.
Dr. Nourian holds B.Sc and M.Sc in Biology and Medical Microbiology, respectively and obtained her Ph.D in Biotechnology/Food Science from McGill University. She has two post-doctoral training in the fields of cell and molecular biology at McGill University and Microbiology at Agriculture and Agri-Food Canada.
Immuni T is pleased that she accepted this appointment and know she will represent the company well and will contribute much to its success.